A stochastic model for the origin and treatment of tumors containing drug-resistant cells

From MaRDI portal
Publication:1820076

DOI10.1007/BF02459682zbMath0613.92006WikidataQ52650549 ScholiaQ52650549MaRDI QIDQ1820076

Andrew J. Coldman, James H. Goldie

Publication date: 1986

Published in: Bulletin of Mathematical Biology (Search for Journal in Brave)




Related Items

Limiting the development of anti-cancer drug resistance in a spatial model of micrometastasesChemotherapeutic treatments: A study of the interplay among drug resistance, toxicity and recuperation from side effectsConflicting objectives in chemotherapy with drug resistanceDynamics of cancer recurrenceStochastic modeling of drug resistance in cancerOn minimising tumoural growth under treatment resistanceScheduling collateral sensitivity‐based cycling therapies toward eradication of drug‐resistant infectionsRole of optimal control theory in cancer chemotherapyThe worst drug rule revisited: mathematical modeling of cyclic cancer treatmentsEvolution of resistance to anti-cancer therapy during general dosing schedulesStochastic Modelling of Multiple Random Genetic Mutations Under the Cancer Stem Cell HypothesisModelling growth of drug resistant cancer populations as a system with positive feedbackA survey of optimization models on cancer chemotherapy treatment planningStochastic modeling of cellular colonies with quiescence: an application to drug resistance in cancerAn elementary mathematical modeling of drug resistance in cancerOptimal control of tumor size used to maximize survival time when cells are resistant to chemotherapyLow-intensity combination chemotherapy maximizes host survival time for tumors containing drug-resistant cellsThe fixed-size Luria-Delbrück model with a nonzero death rateOn the probability of random genetic mutations for various types of tumor growthThe impact of cell density and mutations in a model of multidrug resistance in solid tumorsLarge population solution of the stochastic Luria–Delbrück evolution modelOptimization of an \textit{in vitro} chemotherapy to avoid resistant tumoursDrug kinetics and drug resistance in optimal chemotherapyChemotherapeutic treatments involving drug resistance and level of normal cells as a criterion of toxicityCancer chemotherapy with immunostimulation: A nonhomogeneous stochastic model for drug resistance. I: One drug caseDynamical analysis of tumor-immune-help T cells systemScaling solution in the large population limit of the general asymmetric stochastic Luria-Delbrück evolution processA stochastic model of mutant growth due to mutation in tumors, based on stem cell considerations



Cites Work